• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group

    11/20/24 9:00:00 AM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email

    CHICAGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Zarminali Health, the first outpatient pediatric destination purpose-built to provide modern, seamlessly coordinated primary and specialty care nationwide, today announced $40M in seed financing led by General Catalyst. The company will leverage the latest healthcare technology and an integrated approach to both primary and specialty care that alleviates family burdens and revitalizes patient and clinician experiences. This substantial funding, including a venture debt facility, will fuel the company's go-to-market vision and continue to support the opening of its initial locations in fall 2024 and beyond.

    Pediatric care today is long overdue for change. The current system is highly fragmented, and the disconnect between primary care providers, specialists, and ancillary services places the responsibility of navigating the healthcare system and complex care coordination squarely on families. Meanwhile, pediatricians are overburdened with high caseloads and unsustainable administrative tasks, clinical teams are under-supported with manual processes and outdated technology, and pediatric specialists remain siloed from primary care teams. All of these factors and inefficiencies exacerbate clinician burnout and hinder access to timely care for one of the most vulnerable populations in the country: children.

    Zarminali was formed to deliver a renewed promise for pediatric care by streamlining care journeys for families, improving health outcomes for children, and enabling pediatric clinicians to focus on delivering quality care to their patients. Founded by Danish Qureshi, co-founder and former President and COO of LifeStance Health (NASDAQ:LFST), the company's mission is directly informed by Danish's personal experiences coordinating care for a child with an autoimmune disorder, and the many instances of breakdown in care across pediatric specialists.

    "Zarminali is being painstakingly designed by parents like myself who have struggled against the current flaws of our healthcare system and know that every child deserves amazing care, from birth to adulthood," said Qureshi. "After navigating the broken system with my daughter, I wanted to apply my experience transforming outpatient mental healthcare at LifeStance to improving pediatric care on a national scale. This initial funding round is an immense validator and kickstarts our mission to create a world where every child's health journey is seamlessly coordinated, where advanced technology enhances every interaction, and where our clinicians and team members support each family every step of the way."

    "Pediatrics has long been overlooked, and we deeply share in Zarminali Health's belief that our children and families deserve better care," said Holly Maloney, Managing Director of General Catalyst. "With a strong founding team, collaborative care model, and advanced technology, we believe the team is on the right path to transform pediatric healthcare nationwide."

    Zarminali Health's early team is a highly motivated and experienced group determined to improve pediatric care for all stakeholders. With backgrounds from other scaled national healthcare startups such as VillageMD (Walgreens and the Cigna Group), the team brings years of direct operating experience to tackle the challenges of pediatric care delivery. Additionally, Zarminali Health added its first independent board member in Brandon Kerns, bringing direct, relevant experience from Landmark Health (acquired by United Healthcare), Carebridge (acquired by Elevance), and Main Street Health.

    To learn more about Zarminali Health, and how the company is transforming pediatric care, visit: https://zarminali.com/

    About Zarminali Health

    Zarminali Health, Inc. is building the nation's leading pediatric multispecialty group, focused on supporting families to shape healthy futures for their children – from birth through adulthood – by completely transforming the way pediatric care is delivered nationwide. Zarminali is tackling today's challenges of increased administrative burden on clinicians and a siloed approach to pediatric care through intentional design of care delivery, enhanced by leading technology and collaborative, expert care teams. We are leading the way towards a healthier future for pediatric patients and a happier future for pediatric clinicians nationwide. Visit zarminali.com for more information.

    About General Catalyst

    General Catalyst is a global investment and transformation company that partners with the world's most ambitious entrepreneurs to drive resilience and applied AI. We support founders with a long-term view who challenge the status quo, partnering with them from seed to growth stage and beyond. With offices in San Francisco, New York City, Boston, Berlin, Bangalore, and London, we have supported the growth of 700+ businesses, including Airbnb, Anduril, Applied Intuition, Commure, Glean, Guild, Gusto, Helsing, Hubspot, Kayak, Livongo, Mistral, Ramp, Samsara, Snap, Stripe, Sword, and Zepto.

    Media Contact

    LaunchSquad for Zarminali Health

    [email protected]   



    Primary Logo

    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • What amount of seed financing did Zarminali Health announce, and who led the investment?

      Zarminali Health has secured $40 million in seed financing, led by General Catalyst, to revolutionize the delivery of pediatric care in the U.S.

    • What is the primary mission of Zarminali Health?

      The company aims to streamline care for children, reduce family burdens in coordinating care, and enhance the clinician experience by leveraging modern healthcare technology.

    • Who founded Zarminali Health and what motivated him to start the company?

      Danish Qureshi, co-founder and former President and COO of LifeStance Health, founded Zarminali Health in response to personal experiences navigating pediatric care for his child.

    • When does Zarminali Health plan to begin opening its initial locations?

      Zarminali Health plans to open its first locations in the fall of 2024 as part of its go-to-market strategy following this funding round.

    • What backgrounds does the early team at Zarminali Health have that relates to pediatric care delivery?

      The early team at Zarminali Health brings experience from leading healthcare startups, indicating a robust foundation for tackling pediatric care challenges.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    3/17/2022$19.00 → $10.00Buy → Neutral
    UBS
    More analyst ratings

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group upgraded by Goldman with a new price target

      Goldman upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $10.00

      12/16/24 6:31:31 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    SEC Filings

    See more
    • LifeStance Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/14/25 9:34:10 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeStance Health Group Inc.

      10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/7/25 4:42:46 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by LifeStance Health Group Inc.

      DEFA14A - LifeStance Health Group, Inc. (0001845257) (Filer)

      4/23/25 4:54:39 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Financials

    Live finance-specific insights

    See more
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman

      Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz., Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer. Bourdon, who joined LifeStance as Chief Financial Officer in 2022, is succeeding Ken Burdick, who is retiring from his role as CEO and will assume the role of Executive Chairman. Bourdon has also been appointed to serve on the Board of Directors. In addition, Ryan McGroarty has been appointed to serve as the company's new Chief Financ

      2/27/25 6:02:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025

      SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 27, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 4372752, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentati

      2/6/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Pardo Ryan covered exercise/tax liability with 12,280 shares, decreasing direct ownership by 1% to 915,735 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:52:55 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Director Burdick Kenneth A covered exercise/tax liability with 35,817 shares, decreasing direct ownership by 1% to 3,368,901 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:35 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bourdon David covered exercise/tax liability with 10,884 shares, decreasing direct ownership by 1% to 888,239 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:06 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 4:34:15 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 9:59:56 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/8/24 4:33:25 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

      SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background

      3/12/24 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care